TE_13

Basic information Differential Expression Stage analysis Survival analysis Correlation analysis

TE family MER9a2
TE superfamily ERV2
TE class LTR
Gene FAM41C, -
Class Chimeric, Intergenic
Coding Non-coding
Tumor-specific score 0.50
Counts of samples TCGA_tumor:47; TCGA_normal:16; GTEx:91
TSS chr1(-):898222



Transcript isoforms

Transcript_ID Gene Class Coding ORF Position
teRNA_13.1 - Intergenic Non-coding Non-coding chr1(-):878672,878692,879115,879212,898087,898223
teRNA_13.2 FAM41C Chimeric Non-coding Non-coding chr1(-):868655,868675,874112,875155,876746,877267,879115,879212,898087,898223
teRNA_13.3 FAM41C Chimeric Non-coding Non-coding chr1(-):868655,868675,875040,875155,876746,877267,879115,879212,898087,898223
teRNA_13.4 - Intergenic Non-coding Non-coding chr1(-):878727,878747,879115,879212,898087,898223
teRNA_13.5 FAM41C Chimeric Non-coding Non-coding chr1(-):868655,868675,874112,875155,876746,877245,879115,879212,898087,898223
teRNA_13.6 FAM41C Chimeric Non-coding Non-coding chr1(-):868655,868675,875040,875155,876746,877245,879115,879212,898087,898223


GTEx

The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.




TCGA

The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).




GTEx

The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.




TCGA

The expression of TE-initiated transcript across 33 cancer types from The Cancer Genome Atlas (TCGA).